Financhill
Back

Vivos Therapeutics, Inc. Stock Predictions

Vivos Therapeutics, Inc. Stock Forecast

  • Is Vivos Therapeutics, Inc. Stock Undervalued?
    The current Vivos Therapeutics, Inc. [VVOS] share price is $2.15. The Score for VVOS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • VVOS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Vivos Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Vivos Therapeutics, Inc. Stock Rating

Data Unavailable

Vivos Therapeutics, Inc. Stock Price History

Is VVOS stock going to rise?

  • The current trend is moderately bullish and VVOS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
vivos.com

52-Week Data

52-Week High:
7.95
52-Week Low:
1.98

Prediction Charts

Market Cap:
19.3M
Price in USD:
2.15
Volume:
76.1K
Beta:
6.96

Technical Analysis

SMA50:
2.68
SMA100:
3.56
SMA200:
3.31
52-Wk Change:
-46.65%

Stock Predictions

  • Is Vivos Therapeutics, Inc. stock public?
    Yes, Vivos Therapeutics, Inc. is a publicly traded company.
  • What is the Vivos Therapeutics, Inc. stock quote today?
    The Vivos Therapeutics, Inc. stock price is 2.15 USD today.
  • How to buy Vivos Therapeutics, Inc. stock online?
    You can buy Vivos Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-14 2.38 2.34 2.44 2.30
Nov-17 2.39 2.39 2.48 2.30
Nov-18 2.43 2.47 2.47 2.36
Nov-19 2.41 2.36 2.50 2.33
Nov-20 2.26 2.12 2.48 2.12
Nov-21 2.14 2.20 2.23 2.10
Nov-24 2.23 2.15 2.23 2.03
Nov-25 2.16 2.20 2.23 2.12
Nov-26 2.17 2.24 2.28 2.15
Nov-28 2.28 2.26 2.33 2.24
Dec-1 2.26 2.13 2.28 2.10
Dec-2 2.16 2.05 2.17 2.05
Dec-3 2.04 2.07 2.10 1.98
Dec-4 2.04 2.15 2.16 2.04

Vivos Therapeutics, Inc. Earnings

Data Unavailable

Vivos Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and an increase next year of $0.91 per share.

* Vivos Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.